The conversion of the viral relaxed, circular DNA genome into covalently closed, circular DNA (cccDNA) and its appearance in the nucleus is one of the earliest events in the replication of hepadnaviruses (4) . cccDNA is thought to be the template for transcription of mRNAs and pregenome RNA, the template for synthesis of new DNA genomes by reverse transcription (10) .
We have previously shown that within the first 4 days after infection of primary duck hepatocytes by the duck hepatitis B virus (DHBV), the amount of cccDNA in the infected cells increased to about 50-fold over the amount derived from the infecting virus (10) . This cccDNA amplification was shown to occur through de novo synthesis by reverse transcription rather than through semiconservative replication. Circumstantial evidence suggested that cccDNA amplification occurred through an intracellular pathway prior to virus release rather than through reinfection of cells by progeny virus particles. Subsequent evidence showing that amplification is resistant to the presence in the medium of suramin, a drug that blocks DHBV infection (5) , supports this view (13).
cccDNA levels in persistently infected hepatocytes in vivo have been estimated at various values, ranging from a low of 3 to a high of 50 copies per nucleus. These low copy numbers suggest that amplification of cccDNA in natural infections is confined to the early phase of the infection and that the size of the pool of cccDNA may be limited by specific control mechanisms. It seems likely that without controls to limit amplification of cccDNA in infected cells, continued accumulation of the viral transcriptional template would result in damage to the infected cells. Thus, control of cccDNA amplification is, theoretically, an important feature necessary for the ability of hepadnaviruses to infect cells persistently, without cytopathic effects.
Tuttleman et al. (11) postulated that amplification may be controlled through feedback inhibition of cccDNA synthesis by a viral gene product. We have therefore attempted to identify mutations in viral genes which may influence or destroy cccDNA copy number control. The only viral gene known not to be required for viral DNA synthesis is that encoding the viral envelope proteins, p36 and p17 (1) , which * Corresponding author.
are encoded by the same open reading frame but are initiated from different AUGs (6, 9) . We therefore tested, using site-directed mutagenesis, whether these two proteins are required for control of cccDNA amplification. The results demonstrate that the production of defective viral envelope proteins results in a greatly enhanced accumulation of cccDNA. This enhanced accumulation appears to be due to a failure to turn off cccDNA synthesis at early times after infection. The transient nature of the infection by the envelope-defective mutant suggests that failure to control cccDNA amplification may be cytocidal.
MATERIALS AND METHODS
Cells and cell culture. Transfection of plasmid DNAs was carried out in the chicken hepatoma cell line LMH (2) . LMH cells were maintained in F-12-Dulbecco modified Eagle medium (1:1) supplemented with 10% fetal bovine serum. Primary duck hepatocyte cultures were used for the growth of DHBV (12) . Ducklings were obtained from Metzer Farms or Red Wing Hatcheries, and primary hepatocytes were prepared from 5-to 12-day-old ducklings by perfusion of the liver with collagenase as previously described (12) . Cells were plated at confluence and maintained at 37°C in Leibowitz medium (L-15) supplemented with glucose (1 mg/ml), insulin (1 ,ug/ml), hydrocortisone hemisuccinate (10 ,uM), penicillin (100 ,g/ml), streptomycin (100 ,ug/ml), and dimethyl sulfoxide (1%) (7) .
Plasmids. Infectious DHBV DNA-containing plasmids consisted of EcoRI-linearized DHBV DNA cloned into the plasmid vector pSP65 (Promega Biotec) as a head-to-tail dimer. Mutants ADR1 (DNA-) and 1S (env-), previously described (1), were derived from the wild-type clone pSPD HBV 5.1 (2X) by precise deletion of both copies of DRI, a sequence required for correct minus-and plus-strand initiation (ADRI), or by single base substitutions (T-*A at positions 1327, 1346, and 1349, numbered according to Mandart et al. [3] ) to terminate translation of both envelope proteins p17 and p36 (1S). Plasmids were grown in Escherichia coli DH5a (Bethesda Research Laboratories) and purified through cesium chloride gradients containing ethidium bromide. 2820 SUMMERS ET AL. ously described (8) . Plasmid DNAs (3 ,ug total), either alone or in combination, were added as calcium phosphate precipitates directly to 60-mm dishes of LMH cells containing 3 ml of medium, and the plates were left undisturbed for 15 h. The medium was then removed and replaced with fresh medium. Growth medium was changed again in 2 days, and after 2 more days of incubation, the culture supernatants were removed and used as an inoculum for primary hepatocyte cultures.
Infections. Primary hepatocyte cultures were infected 1 to 3 days postplating. Culture supernatant from transfected LMH cells (0.3 ml) was added directly to the hepatocyte culture medium (4.0 ml), and the inoculated medium was allowed to remain on the cells for 24 h. The inoculum was removed and replaced with fresh medium (day 0). The medium was changed every day thereafter.
Isolation of viral DNA from infected hepatocytes. Infected hepatocytes in 60-mm dishes were lysed by the addition of 1 For the isolation of cccDNA and replicative intermediates, cells were lysed in lysis buffer without pronase, and protein-detergent complexes were precipitated by the addition of 0.25 ml of 2.5 M KCl. The lysates were mixed by shaking, and the insoluble material containing viral replicative intermediates (precipitated because they are covalently bound to protein) and most of the cellular DNA were removed by centrifugation. The supernatant, containing viral cccDNA, was extracted with an equal volume of phenol, and total nucleic acids were precipitated with 2 volumes of ethanol. Replicative intermediates were recovered from the detergent pellet by dissolving in 1 ml of TE containing 0.5 mg of pronase per ml. The pellet was dispersed by intermittent vortex mixing and incubation at 37°C. After 1 h, the digested pellet was extracted with phenol, and total nucleic acids were precipitated with 2 volumes of ethanol.
Analysis of viral DNA. Viral DNA was analyzed by electrophoresis through 1% agarose gels and transferred by blotting to nylon membranes (Hybond-N, Amersham Corp.). Hybridization was carried out at 50 to 52°C in hybridization medium containing 50% formamide as previously described (1) . Hybridization probes were generated by in vitro transcription of pSP65 plasmids containing DHBV DNA cloned behind the SP6 promoter so that the radioactive transcript was complementary to the viral minus strand (11) .
Cesium chloride gradient fractionation of bromodeoxyuridine (BUdR)-substituted DNA was carried out in a vTi8O rotor at 65,000 rpm for 15 h at 25°C. The starting density of cesium chloride was 1.75 g/cm3.
Immunostaining of infected cells. Indirect immunofluorescent analysis was carried out on cells that were fixed at -20°C in 95% ethanol-5% acetic acid. Fixed cells were incubated with rabbit antisera, kindly supplied by W. S. Mason, directed against either DHBV core protein or DHBV surface antigen. After washing, the cells were incubated with rhodamine-conjugated goat anti-rabbit immunoglobulin G (Organon Teknika).
RESULTS
We have previously described a system for the production of infection-competent DHBV particles containing mutant viral genomes (1) . This system employs cotransfection of a human hepatoma cell line, Huh-7, with a plasmid containing a mutated DHBV genome to be packaged, and a plasmid which provides viral proteins for packaging in trans but which cannot synthesize infectious virus because of a deletion of both copies of DR1 (ADR1). Since the function of DR1 acts only in cis, viral particles produced are free of DNA-containing helper virus and contain only the DNA genome of the mutant. We have adapted this system to transfection of the chicken hepatoma cell line LMH (2) , which has been reported to produce at least 10- BUdR (10 ,u.g/ml) was added at the time of addition of the inoculum, and after 4 days, cccDNA was extracted and fractionated in isopycnic cesium chloride density gradients. Fractions were analyzed by electrophoresis through a 1% agarose gel and blot hybridization. The cccDNA samples in cesium chloride density gradients. Figure 3 shows the results of agarose gel electrophoresis of the gradient fractions. As previously observed (11) , amplification of cccDNA by wild-type-infected cells occurred between 1 and 4 days postinfection, as judged by the amount of density-labeled cccDNA that was present. Between 4 and 7 days and 7 and 10 days postinfection, decreasing amounts of cccDNA were produced de novo, corresponding to the lack of accumulation seen in the unfractionated sample. In mutant-infected cells, density-labeled cccDNA appeared in increasing amounts in the sequential labeling periods, indicating an accelerating rate of synthesis. This increasing rate of synthesis was reflected in a striking accumulation of cccDNA in the infected cells which was clearly different from that seen in the wild-type infection.
Curiously, a large amount of relaxed circular viral DNA was seen in the cccDNA fraction from wild-type-infected cells at 10 days postinfection. The presence of relaxed, circular viral DNA in this fraction suggests that, unlike relaxed, circular DNA from viral cores, it was not covalently linked to protein. This DNA was not derived from nicking of cccDNA during its isolation, since its density distribution in CsCl gradients was unlike that of authentic cccDNA from the same sample. Since the density labeling characteristics of this species resembled those of cccDNA at 10 days in cells infected with the 1S mutant, it is possible that this DNA represents an immediate precursor to cccDNA whose conversion to cccDNA was blocked by envelope expression in the wild-type infection. However, other explanations are also possible.
In three separate experiments, accumulation of non-protein-bound, relaxed, circular DNA after 10 Figure 2B ) are also consistent with a defect in initiation of a second round of infection in the presence of suramin. We do not know, at this time, the structure of this species of viral DNA, nor do we know whether its accumulation occurs in the initially infected cells or in the uninfected cell population which has been exposed to progeny virus.
Envelope proteins are required to establish a persistent infection. The long-term consequences of a lack of regulation of cccDNA synthesis were examined in infected hepatocytes by observing the fate of wild-type-or mutant-infected cells for 20 days postinfection. Total DNA was extracted from the cell layer at various times after infection and analyzed by Southern blot hybridization (Fig. 4) . Viral DNA in wildtype-infected cultures continued to increase throughout the experimental period, while the level of viral DNA in mutantinfected cultures declined rapidly after 12 Fig. 2 were fractionated by buoyant density in isopycnic cesium chloride gradients, and the fractions were analyzed by electrophoresis through a 1% agarose gel and blot hybridization. The buoyant densities corresponding to fully substituted (h/h) and unsubstituted (1/1) DNA and the migration positions of relaxed circular DNA (rc) and cccDNA (ccc) are indicated. Cultures were fixed and stained for viral antigens by immunofluorescence (Fig. 5) . Single cells stained for both capsid antigens and envelope antigens were seen at day 6 in wild-type-infected cultures, but only cells stained for capsid antigens were seen in the mutant-infected cultures. At 20 days postinfection, the spread of wild-type virus in the cultures was evidenced by the greatly increased number of capsid antigen-stained cells. In the mutant-infected cultures, few cells stained for capsid antigens were seen after 20 days. The scarcity of infected cells corresponded to the disappearance of viral replicative DNA from the mutant-infected cultures.
A transient infection, similar to that seen in cultures infected by the mutant virus, could not have been observed in the cultures infected by wild-type virus, since the spread of progeny virus would have masked any disappearance of replicative forms in the initial infected cells. Therefore, we carried out an infection of primary hepatocytes with mutant and wild-type virus and incubated the infected cells in the presence of suramin to inhibit virus spread (5) (Fig. 6) . Suramin added to the culture medium immediately after removal of the inoculum did not inhibit the accumulation of replicative intermediates in either infected culture, and at times at which viral DNA had significantly diminished in the mutant-infected cells, cells infected by wild-type virus were still accumulating viral DNA. This result indicates that the envelope mutation destroyed the ability of the mutant genome, compared with that of the wild type, to establish a persistent infection in cultured hepatocytes. Upon removal of the inoculum after 24 h, the medium was replaced with hepatocyte medium containing suramin (100 ,ug/ml). The infected cells were maintained in the presence of suramin until they were harvested at the times indicated. Total DNA was extracted, and viral specific DNA was analyzed by electrophoresis through 1% agarose and blot hybridization. The positions of viral DNA forms are indicated as in previous figures. Molecular weight markers (as in Fig. 1 ) are in the right lanes of each panel.
by which this suppression of cccDNA synthesis occurs was not elucidated by these experiments.
Tuttleman et al. (11) showed that cccDNA amplification involves the conversion of cytoplasmic relaxed circular viral DNA to nuclear cccDNA. Virtually all cytoplasmic, relaxed, circular DNA is synthesized inside, and contained within, viral nucleocapsids. In a wild-type infection, conversion of a small fraction of this DNA to nuclear cccDNA must involve several steps: nuclear transport, unpackaging, and DNA repair and ligation. The order in which these processes occur is not known.
The majority of cytoplasmic nucleocapsids containing relaxed circular DNA are ultimately secreted from the cell as mature virions, enveloped in lipid-containing membranes containing the viral envelope proteins. Therefore, there are at least two alternative pathways for determining the fate of cytoplasmic DNA; one of these pathways depends on viral envelope production. The suppression of cccDNA synthesis by envelope proteins might be explained as a selection of all capsids for the secretory pathway to the exclusion of the pathway for conversion to cccDNA. For example, the interaction of a nucleocapsid with one or both envelope proteins may render that capsid unavailable for cccDNA synthesis. Lack of such an interaction may result in efficient utilization of the nucleocapsid for cccDNA synthesis. The specific mechanisms by which nucleocapsids are selected for either pathway are not known.
For such a model to account for the suppression of amplification, it is necessary to explain how cccDNA synthesis could occur at early times after infection but be suppressed at later times. This temporal change in regulation could occur This regulation would appear to be required for maintenance of a persistent infection in vitro and possibly in vivo. One can imagine that high levels of virus replication combined with low levels of secretion could be cytocidal, and this effect would account for the failure of the envelopedefective mutant genome to establish a persistent infection in vitro. However, no direct evidence of virus-specific cell death in the mutant-infected cultures was obtained, since the numbers of infected hepatocytes were too low to allow a distinction of virus-induced cell death from normal attrition in primary cultures. Both mutant-and wild-type-infected cell layers remained healthy during long-term infection, although a large proportion of the cells was infected by day 20 in the wild-type-infected cultures. This observation and the persistence of viral DNA replicative intermediates in the presence of suramin strongly suggest that wild-type viral infections are persistent and noncytocidal in vitro. Careful analysis of supernatant fluids of wild-type-and mutant-infected cultures for products of specific lysis of infected cells will be necessary to establish whether a cytocidal effect is the basis for the transient nature of the infection by the envelope-defective virus.
Recently, we have found that mutation of the pre-S envelope protein alone is sufficient to destroy both control of cccDNA amplification and the secretion of DNA-containing particles. This finding suggests that the pre-S protein may physically bind to the viral nucleocapsid to promote packaging and that such a physical interaction may also be responsible for the control of cccDNA synthesis. Mutational mapping of the pre-S domains required for packaging or control of cccDNA amplification or both may help to resolve whether these domains actually recognize binding receptors on the surface of the nucleocapsid.
